During the past decade, Piedmont Healthcare conducted 39 clinical trials. In the 10-year time frame, 39 clinical trials started and 9 clinical trials were completed, i.e. on average, 23.1% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 6 clinical trials were completed. i.e. 28.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Piedmont Healthcare" #1 sponsor was "Actelion" with 2 trials, followed by "Edwards Lifesciences" with 2 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored, "JenaValve Technology, Inc." with 2 trials sponsored and "M.D. Anderson Cancer Center" with 2 trials sponsored. Other sponsors include 28 different institutions and companies that sponsored additional 37 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Piedmont Healthcare" #1 collaborator was "National Cancer Institute (NCI)" with 3 trials as a collaborator, "Incyte Corporation" with 2 trials as a collaborator, "Biosense Webster, Inc." with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Medpace, Inc." with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Piedmont Healthcare" are "Mitral Regurgitation" (3 trials), "Aortic Regurgitation" (2 trials), "Atrial Fibrillation" (2 trials), "Diabetic Foot Ulcer" (2 trials) and "Stage IIB Breast Cancer AJCC v6 and v7" (2 trials). Many other conditions were trialed in "Piedmont Healthcare" in a lesser frequency.

Most popular intervention types in "Piedmont Healthcare" are "Drug" (21 trials), "Device" (16 trials), "Other" (4 trials), "Procedure" (4 trials) and "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Baricitinib" (2 trials), "Bevacizumab" (2 trials), "Quality-of-Life Assessment" (2 trials) and "ADT" (1 trials). Other intervention names were less common.

The vast majority of trials in "Piedmont Healthcare" are 40 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Piedmont Healthcare". undefined are not yet recruiting, 18 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Piedmont Healthcare, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Piedmont Healthcare, 1 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 12 trials that are defined as “Not Applicable".